Literature DB >> 10714362

Follicle-stimulating hormone ligand and receptor mutations, and gonadal dysfunction.

J Levallet1, P Pakarinen, I T Huhtaniemi.   

Abstract

In contrast to the general contention, infertility can be an inherited condition. Some of the genetic causes of male and female infertility have turned out to be due to inactivating mutations in the gonadotropin and gonadotropin receptor genes. The topic of the present text is to review current knowledge on mutations affecting the function of follicle-stimulating hormone (FSH). This gonadotropin, by binding to its specific G protein-coupled cell membrane receptor (FSHR), is important for normal gonadal function. Mutations affecting gonadotropin genes are extremely rare, but recent genetic studies have revealed that the pathogenesis of subfertility or infertility can be due to mutations in the FSH receptor (FSHR) gene. While mutations affecting FSHR are sporadic, polymorphism of the FSHR gene seems to be a common phenomenon. To date, six inactivating and only one activating mutation have been detected in the FSHR gene. In contrast to LHR gene, the majority of these mutations affect the extracellular domain of the receptor. Together with animal models using the transgenic and knock-out approaches, systematic analysis of alterations in the FSHR gene increases our knowledge on the structure and function of the FSHR and demonstrates that the integrity of each FSHR segment is required for proper expression of the fully active protein and for normal gonadal function. Mutations in the FSHR gene have different consequences in the reproductive function depending on the sex of the patient: while normal ovarian function is critically dependent on FSH, male fertility is possible with minimal or absent FSH action.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10714362     DOI: 10.1016/s0188-0128(99)00058-5

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  7 in total

Review 1.  Are circulating gonadotropin isoforms naturally occurring biased agonists? Basic and therapeutic implications.

Authors:  Brian J Arey; Francisco J López
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 2.  Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone.

Authors:  Kadri Haller-Kikkatalo; Andres Salumets; Raivo Uibo
Journal:  Clin Dev Immunol       Date:  2011-10-05

3.  Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats.

Authors:  Victoria Tyndall; Marie Broyde; Richard Sharpe; Michelle Welsh; Amanda J Drake; Alan S McNeilly
Journal:  Reproduction       Date:  2011-10-20       Impact factor: 3.906

4.  The impact of FSH receptor polymorphism on time-to-pregnancy: a cross-sectional single-centre study.

Authors:  Birute Zilaitiene; Marius Dirzauskas; Rasa Verkauskiene; Rytas Ostrauskas; Joerg Gromoll; Eberhard Nieschlag
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-28       Impact factor: 3.007

5.  Variants Ala307Ala and Ser680Ser of 307 and 680 FSHr polymorphisms negatively influence on assisted reproductive techniques outcome and determine high probability of non-pregnancy in Caucasian patients.

Authors:  Belén Monge-Ochoa; Luis Montoro; Elisa Gil-Arribas; Julio Montoya; Eduardo Ruiz-Pesini; Manuel J López-Pérez; Francisco de Castro; Carmen Díez-Sánchez
Journal:  J Assist Reprod Genet       Date:  2021-08-03       Impact factor: 3.357

6.  Association of follicle-stimulating hormone receptor polymorphisms with ovarian response in Chinese women: a prospective clinical study.

Authors:  Yuanliang Yan; Zhicheng Gong; Lu Zhang; Yanping Li; Xiong Li; Lin Zhu; Lunquan Sun
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

Review 7.  Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker-The Follicle-To-Oocyte (FOI) Index.

Authors:  Carlo Alviggi; Alessandro Conforti; Sandro C Esteves; Roberta Vallone; Roberta Venturella; Sonia Staiano; Emanuele Castaldo; Claus Yding Andersen; Giuseppe De Placido
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-17       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.